vTv Therapeutics (VTVT) EBT Margin Growth (3y) (2017 - 2024)
Powered by 
Analysis
vTv Therapeutics (VTVT) EBT Margin Growth (3y) (2017 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | -265.00 |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 636.00 |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | 3,137.00 |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | 625.00 |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | -2,179.00 |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | -977.00 |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | BeOne Medicines | 40.49 Bn | 35.39 Bn | 1.53 Bn | 8,006.00 |
| 9 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 1,581.00 |
| 10 | vTv Therapeutics | 413.85 Mn | 413.85 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 7.93 Mn |
| Mar 31, 2024 | 861.00 |
| Dec 31, 2022 | 3.06 Mn |
| Jun 30, 2022 | -4.52 Mn |
| Mar 31, 2022 | -2,884.00 |
| Dec 31, 2021 | -10.53 Mn |
| Sep 30, 2021 | 1,260.00 |
| Jun 30, 2021 | -896,450.00 |
| Mar 31, 2021 | -11,795.00 |
| Dec 31, 2020 | 594,443.00 |
| Sep 30, 2020 | 5.02 Mn |
| Mar 31, 2020 | -4.19 Mn |
| Dec 31, 2019 | -6.22 Mn |
| Sep 30, 2019 | -3.90 Mn |
| Jun 30, 2019 | 775,703.00 |
| Mar 31, 2019 | 316,339.00 |
| Dec 31, 2018 | 484,188.00 |
| Sep 30, 2018 | 732,686.00 |
| Jun 30, 2018 | 908,551.00 |
| Mar 31, 2018 | 1.91 Mn |